Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Chatters1111on Sep 23, 2019 11:05pm

123 Views

Post# 30157321

RE:RE:RE:RE:Let’s go

I think you need to reread your post. Howie has been there th whole time. Yes he’s given us a signed deal. Which is great. People want to see the numbers. That’s what there use to. This deal is different because 1067 can still be made into multiple deals. So that’s why there’s no numbers attached. For me it’s common sense if I owned something and could sell it multiple times, why would I tell anyone what I sold it for. Keep the deals coming Howie. Slow and steady climb is what we want.

Bullboard Posts

Debt-free cannabis company set for next stage of growth